Your browser doesn't support javascript.
loading
Cancer diagnosis in Brazil in the COVID-19 era.
Marques, Nelson Pereira; Silveira, Denise Maria M; Marques, Nádia Carolina Teixeira; Martelli, Daniella Reis Barbosa; Oliveira, Eduardo A; Martelli-Júnior, Hercílio.
Afiliação
  • Marques NP; University of Campinas, FOP-UNICAMP, São Paulo, Brazil. Electronic address: neomarques@hotmail.com.
  • Silveira DMM; Primary Care Postgraduate Program, State University of Montes Claros Unimontes, Minas Gerais, Brazil.
  • Marques NCT; José do Rosario Vellano University, Minas Gerais, Brazil; Center for Rehabilitation of Craniofacial Anomalies, University of Alfenas, Minas Gerais, Brazil.
  • Martelli DRB; Primary Care Postgraduate Program, State University of Montes Claros Unimontes, Minas Gerais, Brazil; University of California, San Diego, La Jolla, CA, USA.
  • Oliveira EA; University of California, San Diego, La Jolla, CA, USA; Department of Pediatrics, Faculty of Medicine, Federal University of Minas Gerais (UFMG), Minas Gerais, Brazil.
  • Martelli-Júnior H; Primary Care Postgraduate Program, State University of Montes Claros Unimontes, Minas Gerais, Brazil; Center for Rehabilitation of Craniofacial Anomalies, University of Alfenas, Minas Gerais, Brazil.
Semin Oncol ; 48(2): 156-159, 2021 04.
Article em En | MEDLINE | ID: mdl-33478743
The comprehensive care and treatment for cancer patients in Brazil, regulated by the National Cancer Prevention and Control Policy, is provided by Brazilian Unified Healthcare System (SUS) in certified health institution. Due the COVID-19 pandemic, several restrictive measures have been implemented by the State federation's governments, and cancer diagnosis reference centers were also impacted by these measures. Thus, this study aimed to compare SUS-oriented cancer diagnosis in Brazil before and during the pandemic so far. The average number of cancer diagnoses has dropped considerably in all Brazilian Regions since the pandemic period started. The number of new cancer cases has plunged in all regions, ranged from -24.3% in the North to -42.7% in Northeast region. The overall Brazilian average deficit reached 35.5%, corresponding to about 15,000 undiagnosed cases of cancer monthly. The pandemic period has dramatically reduced the diagnosis of new cases of cancer in Brazil, since consultations in public health services were compromised by restrictive measures. Therefore, effective measures must be urgently put in action in order to minimize the damage, and consequently, the negative health impacts caused by the COVID-19 pandemic in the care of cancer patients.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Detecção Precoce de Câncer / SARS-CoV-2 / COVID-19 / Neoplasias Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Semin Oncol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Detecção Precoce de Câncer / SARS-CoV-2 / COVID-19 / Neoplasias Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: Semin Oncol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos